NCT06794268View on ClinicalTrials.gov

A Study to Patients With Relapsed/Refractory Follicular Lymphoma Treated With Liso-cel (Lisocabtagene Maraleucel) in the Post Marketing Setting

RecruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

February 4, 2025

Primary Completion Date

August 31, 2044

Study Completion Date

August 31, 2044

Conditions

Follicular Lymphoma

Interventions

BIOLOGICAL

Lisocabtagene maraleucel

As per product label

Trial Locations (1)

53226

RECRUITING

CIBMTR, Milwaukee

All Listed Sponsors

lead

Juno Therapeutics, Inc., a Bristol-Myers Squibb Company

INDUSTRY